Cardiomyopathy in Pregnancy: A Review Literature

Ayu Asri Devi Adityawati, Anna Fuji Rahimah, Heny Martini, Cholid Tri Tjahjono



BACKGROUND: Pregnancy is an experience that many women can achieve. Pregnancy is generally well tolerated in asymptomatic patients with cardiomyopathies but in restrictive form cardiomyopathy, pregnancy cannot be tolerated because of poor prognosis. Prior cardiac events, poor functional class (New York Heart Association class III or IV), or advanced left ventricular systolic dysfunction are present, the risk of maternal cardiac complications during pregnancy are markedly increased. Worsening of the clinical condition can occur during pregnancy, despite intensive medical treatment. Although the incident of cardiovascular disease is present 0.5-4% in developed countries, our knowledge about various of cardiomyopathy and pregnancy should be updateable.

CONCLUSION: Our literature provide three types of cardiomyopathy in pregnancy with an example condition for each type that relevant during pregnancy. Peripartum cardiomyopathy is the most common form of cardiomyopathy occured in pregnancy therefore a thorough review is needed to give best outcome for pregnancy. Arryhtmia is the commonnest form in hypertrophic cardiomyopathy which need to be regularly monitored and measure should be taken if the arryhtmia is life threatening for mother and the child. Cardiac amyloidosis is the common form of restrictive cardiomyopathy in pregnancy.

Keywords: Pregnancy; Cardiomyopathy; Peri Partum Cardio Myopathy (PPCM), Pregnancy, Heart Failure



Cardiomyopathy; Heart Failure, Peri Partum Cardio Myopathy (PPCM), Pregnancy

Full Text:



Adamson DL, Nelson-Piercy C. Managing palpitations and arrythmias during pregnancy. Heart. 2007 Dec; 93(12): 1630–1636.

Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509–13

Arany Z. Understanding peripartum cardiomyopathy. Annu Rev Med 2018;69:165-76. 10.1146/annurevmed-041316-090545 pmid:2881323

Banayan J, Rana S, Mueller A, et al. Cardiogenic shock in pregnancy: analysis from the National Inpatient Sample. Hypertens Pregnancy 2017;36:117–23

Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 2016; 18:1096–105

Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am CollCardiol 2013;62:1715–23

Blauwet LA, Silwa K. Peripartum cardiomyopathy. Obstet Med. 2011 Jun; 4(2): 44–52.

Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., ...&Pahl, E.. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation, 2016, 134.23: e579-e646.

Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Eleventh edition. Philadelphia, PA: Wolters Kluwer, 2017

Davis MB, Walsh MN. Cardio-obstetrics. CircCardiovascQual Outcomes 2019;12:e005417.

Davis, M. B., Arany, Z., McNamara, D. M., Goland, S., &Elkayam, U. Peripartum Cardiomyopathy: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 2020, 75.2: 207-221.

Elliott, P. Cardiomyopathy. Diagnosis and management of dilated

cardiomyopathy. Heart 2000. 84 (1): 106–112

Felker, G.M., Thompson, R.E., Hare, J.M. et al. Underlying causes

and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000. 342 (15): 1077–1084

Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo ClinProc 2005;80:1602–6

Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. AfricanAmerican women have a higher risk for developing peripartum cardiomyopathy. J Am CollCardiol 2010;55(7):654–9

Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142:e153–e203. doi: 10.1016/j.jtcvs.2011.10.020.

Goland S, van Hagen IM, Elbaz-Greener G et al. Pregnancy in Woman with Hypertrophic Cardiomyopathy. Eur Heart J. 2017.

Greutmann, M., & Silversides, C. K. The ROPAC registry: a multicentre collaboration on pregnancy outcomes in women with heart disease. 2013.

Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013;108:366.

Honigberg MC, Cantonwine DE, Thomas AM, Lim KH, Parry SI, McElrath TF. Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia. J Perinatol 2016;36:172-7. 10.1038/jp.2015.170 pmid:26583938

Honigberg, M. C., &Givertz, M. M. Peripartum cardiomyopathy. Bmj, 2019, 364: k5287.

Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 2007;17:228–33

Japp, A.G., Gulati, A., Cook, S.A. et al. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 2016. 67 (25): 2996–

Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 2011;75:1975–81

Lewey, J., &Haythe, J. Cardiomyopathy in pregnancy. In: Seminars in perinatology. WB Saunders, 2014. p. 309-317.

Maron MS, Maron BJ. Clinical impact of contemporary cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy. Circulation 2015;132:292-8

McKenna, W. J., Maron, B. J., &Thiene, G. Classification, epidemiology, and global burden of cardiomyopathies. Circulation research, 2017, 121.7: 722-730.

McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy associated cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905– 14.

Moiz B. A review of hemostasis in normal pregnancy and puerperium. Nat J Health Sci 2017; 2:123–7

Muchtar E, Blauwet Gertz MA. Restrictive cardiomyopathy: Genetics, pathogenesis, clinical manifestation, diagnosis and therapy. Circulation Research. 2017;121:819–837

Nihoyannopoulos P, Dawson D. Restrictive cardiomyopathies. European Journal of Echocardiography, Volume 10, Issue 8, December 2009, Pages iii23–iii33

Owens AT. Pregnancy in hypertrophic cardiomyopathy. European Heart Journal, Volume 38, Issue 35, 14 September 2017, Pages 2691–2692.

Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 1995;129:421-2. 10.1016/0002-8703(95)90032-2 pmid:7832124

Pieper PG, Walker F. Pregnancy in woman with hypertrophic cardiomyopathy. Neth Heart J. 2013 Jan; 21(1): 14–18.

Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011;32:3147–3197.

Roos-Hesselink, J. W., Ruys, T. P., Stein, J. I., Thilen, U., Webb, G. D., Niwa, K., ...&Tavazzi, L. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. European heart journal, 2013, 34.9: 657-665.

Schaufelberger, M. Cardiomyopathy and pregnancy. Heart, 2019, 105.20: 1543-1551.

Seldin DC, Berk JL, Sam F, Sanchorawala V. Amyloidotic Cardiomyopathy: Multidiscplinary Approach to Diagnosis and Treatment. Heart Fail Clin. 2011 Jul; 7(3): 385–393.

Shahul S, Medvedofsky D, Wenger JB, et al. Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy. Hypertension 2016;67:1273-80. 10.1161/ HYPERTENSIONAHA.116.07252 pmid:27113052

Spiegelman J., Meng L.M., Haythe J., et al. Cardio-Obstetrics: A Practical Guide to Care for Pregnant Cardiac Patients. CRC Press. 2020

Stergiopoulos, K., & Lima, F. V. Dilated Cardiomyopathy and Pregnancy. Cardiac Problems in Pregnancy, 2019, 155-166.

Tintelen JPV, Pieper PG, Spaendonck-Zwarts KY, Berg MP. Pregnancy, cardiomyopathies, and genetics. Cardiovascular Research, Volume 101, Issue 4, 15 March 2014, Pages 571–578.

Tromp CHN, Nanne ACM, Pernet PJM, et al. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011;19:134–136. doi: 10.1007/s12471-011-0077-5.

Ueda Y, Kamiya CA, Nakanishi A, et al. Cardiomyopathy phenotypes and pregnancy outcomes with left ventricular noncompaction cardiomyopathy. Int Heart J 2018;59:862–7.

Ware JS, Li J, Mazaika E, et al. IMAC-2 and IPAC Investigators. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 2016;374:233-41. 10.1056/ NEJMoa1505517 pmid:26735901

Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: an ominous diagnosis. ObstetGynecol 1997;176(1 Pt 1):182–8

Yang Y, Rodriguez JE, Kitsis RN. A microRNA links prolactin to peripartum cardiomyopathy. J Clin Invest 2013;123:1925-7. 10.1172/ JCI69286 pmid:23619357

Yaranov, D., & Alexis, J. D. Heart Disease in Pregnancy: A Special Look at PeripartumCardiomyopathy. Cardiovascular Innovations and Applications, 2019, 3.4: 403-408.



  • There are currently no refbacks.

Copyright (c) 2021 Ayu Asri Devi Adityawati, Anna Fuji Rahimah

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.